FEATURED

FDA Accepts Biologics License Application for Duchenne Muscular Dystrophy Cardiomyopathy Treatment

  • All
  • Education
  • Events
  • Press Releases
See more news
See more press releases

Social media

At #WMS2025, the #NCNP shared 3.5-year data on brogidirsen (NS-089/NCNP-02) for Duchenne muscular dystrophy, showing sustained motor function, strong dystrophin expression, and no serious AEs.

A big step for #Duchenne care!
πŸ”— https://ow.ly/sHE850Xb5tJ https://x.com/NSPharmaInc/status/1978105321080988032/photo/1

Our team had a wonderful time in Vienna last week for #WMS2025!

It was an honor to present our latest clinical research on the promising potential of NS-089/NCNP-02 (Brogidirsen).

Missed the presentation? View the poster here: https://ow.ly/eUbR50XatcC

#Duchenne #GeneTherapy https://x.com/NSPharmaInc/status/1977736833967489241/photo/1

#WorldMentalHealthDay is a reminder that wellness isn’t just about taking care of ourselves, it’s about taking care of each other. πŸ’š

How do you and your team prioritize mental health and wellness?✨

#NSPLife #WellnessTogether #TeamFirst https://x.com/NSPharmaInc/status/1976649467303460960/photo/1

Our colleague Victoria Ramirez, a #BreastCancer survivor and volunteer with the @AmericanCancer Society is joining the Making Strides Against Breast Cancer walk on Saturday, October 25!

Visit https://ow.ly/o5Ne50X8shh to get involved!

#BreastCancerAwareness #MakingStrides https://x.com/NSPharmaInc/status/1976286530676117915/photo/1

We’re proud to partner with the @JettFoundation in our shared mission to empower people and families living with #Duchenne!πŸ’™

Learn more about the impact of our partnership and our vision for the DMD community: https://lnkd.in/eixrBeFp

#RareDiseases #PatientSupport

Jett Foundation @JettFoundation

Since 2017, NS Pharma and Jett Foundation have teamed up to support individuals and families impacted by Duchenne - from strengthening community programming to engaging in events, research, and direct patient support.

πŸ”— Read about our partnership: https://t.co/WJ777F4uJT https://t.co/TIYGGsC4dz

#WelcomeToTheTeam, Dino Sirianni! πŸ‘‹

Dino joins NSP as Key Account Manager, bringing experience from Amneal Biosciences, American Regent, Pfizer & EKR Therapeutics.

In his spare time, he enjoys playing golf and spending time with the family!

#NSPLife #NewHire https://x.com/NSPharmaInc/status/1975924868483817980/photo/1

We're in Austria for #WMS2025!

Don't miss the poster presentation (658P) by the National Center of Neurology and Psychiatry (NCNP) in the exhibit hall on October 8.

We look forward to sharing this our latest data with the community and hope to see you there!

#GeneTherapy https://x.com/NSPharmaInc/status/1975562483998794142/photo/1